205 related articles for article (PubMed ID: 30518951)
21. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
22. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
Ren L; Deng B; Saloura V; Park JH; Nakamura Y
Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
[TBL] [Abstract][Full Text] [Related]
23. let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer.
Chhabra R
Sci Rep; 2018 May; 8(1):7840. PubMed ID: 29777148
[TBL] [Abstract][Full Text] [Related]
24. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153
[TBL] [Abstract][Full Text] [Related]
25. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
26. ΔNp63α mediates sulforaphane suppressed colorectal cancer stem cell properties through transcriptional regulation of Nanog/Oct4/Sox2.
Chen Y; Wang MH; Wu JY; Zhu JY; Xie CF; Li XT; Wu JS; Geng SS; Li YD; Han HY; Zhong CY
J Nutr Biochem; 2022 Sep; 107():109067. PubMed ID: 35609851
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
[TBL] [Abstract][Full Text] [Related]
28. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
29. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
30. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
31. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
[TBL] [Abstract][Full Text] [Related]
32. SOX2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP production.
Mauro-Lizcano M; Sotgia F; Lisanti MP
Aging (Albany NY); 2022 Dec; 14(24):9877-9889. PubMed ID: 36566021
[TBL] [Abstract][Full Text] [Related]
33. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.
Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X
Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581
[TBL] [Abstract][Full Text] [Related]
34. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
35. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
[TBL] [Abstract][Full Text] [Related]
36. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
37. Transfection of T-Box Transcription Factor
Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
39. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
40. NF-YA transcriptionally activates the expression of SOX2 in cervical cancer stem cells.
Yang WT; Zhao ZX; Li B; Zheng PS
PLoS One; 2019; 14(7):e0215494. PubMed ID: 31365524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]